LMR Partners’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-87,500
Closed -$29.8K 1376
2024
Q1
$29.8K Hold
87,500
﹤0.01% 1015
2023
Q4
$20.1K Hold
87,500
﹤0.01% 836
2023
Q3
$14.4K Hold
87,500
﹤0.01% 805
2023
Q2
$13.5K Hold
87,500
﹤0.01% 749
2023
Q1
$906K Hold
87,500
0.01% 620
2022
Q4
$879K Hold
87,500
0.02% 746
2022
Q3
$859K Hold
87,500
0.02% 777
2022
Q2
$856K Hold
87,500
0.01% 802
2022
Q1
$854K Hold
87,500
0.01% 868
2021
Q4
$853K Hold
87,500
0.01% 781
2021
Q3
$849K Hold
87,500
0.01% 684
2021
Q2
$82K Buy
+87,500
New +$69.9K ﹤0.01% 903

Other funds holding AONCW

LMR Partners's AONCW Position: Q2 2024 in Review

LMR Partners sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 87,500 shares — an estimated $29.8K sold.

LMR Partners first reported a position in AONCW in Q2 2021 and held it in 12 quarters. The position peaked at $906K in Q1 2023. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

  • LMR Partners reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • LMR Partners sold 87,500 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $29.8K.
  • LMR Partners first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 12 quarters.
  • LMR Partners's American Oncology Network, Inc. Warrant position peaked at $906K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.